Skip to main content
Erschienen in: World Journal of Pediatrics 4/2019

25.03.2019 | Original Article

Clinical characteristics and beta-cell function of Chinese children and adolescents with type 2 diabetes from 2009 to 2018

verfasst von: Zhen-Ran Xu, Miao-Ying Zhang, Jin-Wen Ni, Ruo-Qian Cheng, Zhang-Qian Zheng, Li Xi, Fei-Hong Luo

Erschienen in: World Journal of Pediatrics | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

The limited available studies have unveiled different natural histories and prognosis associated with pediatric type 2 diabetes (T2D) and adult T2D. To date, data on the clinical features, metabolic profiles and beta-cell function characteristics are still limited in the Chinese pediatric T2D population.

Methods

A total of 56 children with T2D, 31 with prediabetes and 159 with obesity were recruited. Clinical characteristics, metabolic profiles, beta-cell function and insulin resistance were analyzed.

Results

The mean onset age of T2D was 12.35 ± 1.99 (7.9–17.8) years, and 7% of children were younger than 10 years; 55% of them were male, 57% had a family history of diabetes and 64% had classic symptoms, and 25% had a low or high birth weight. 89% of T2D patients were obese or overweight. A total of 58% of the patients with prediabetes were male. The fast serum C-peptide level was highest in the obesity group (P < 0.001), and there was no significant difference between the T2D and prediabetes groups. The mean homeostatic model of assessment of beta-cell function was the highest in the obesity group and was lowest in the T2D group (P < 0.001). The T2D group had the most serious lipid metabolism disorder, with the highest levels of total triglycerides, total cholesterol, and low density lipoprotein and the lowest high density lipoprotein level among the three groups.

Conclusions

A younger onset age and greater male susceptibility were found in Chinese pediatric T2D patients, and there was a stepwise deterioration trend in beta-cell function among patients with obesity, prediabetes and T2D. Based on our results, together with the SEARCH study results, an early screening and intervention program for T2D is recommended in high-risk or obese Chinese pediatric populations starting at 7 years.
Literatur
1.
Zurück zum Zitat Dabelea D, Hanson RL, Bennett PH, Roumain J, Knowler WC, Pettitt DJ. Increasing prevalence of Type II diabetes in American Indian children. Diabetologia. 1998;41:904–10.CrossRefPubMed Dabelea D, Hanson RL, Bennett PH, Roumain J, Knowler WC, Pettitt DJ. Increasing prevalence of Type II diabetes in American Indian children. Diabetologia. 1998;41:904–10.CrossRefPubMed
2.
Zurück zum Zitat Fazeli Farsani S, van der Aa MP, van der Vorst MM, Knibbe CA, de Boer A. Global trends in the incidence and prevalence of type 2 diabetes in children and adolescents: a systematic review and evaluation of methodological approaches. Diabetologia. 2013;56:1471–88.CrossRefPubMed Fazeli Farsani S, van der Aa MP, van der Vorst MM, Knibbe CA, de Boer A. Global trends in the incidence and prevalence of type 2 diabetes in children and adolescents: a systematic review and evaluation of methodological approaches. Diabetologia. 2013;56:1471–88.CrossRefPubMed
3.
Zurück zum Zitat Pettitt DJ, Talton J, Dabelea D, Divers J, Imperatore G, Lawrence JM, et al. Prevalence of diabetes in US youth in 2009: the SEARCH for diabetes in youth study. Diabetes Care. 2014;37:402–8.CrossRefPubMedPubMedCentral Pettitt DJ, Talton J, Dabelea D, Divers J, Imperatore G, Lawrence JM, et al. Prevalence of diabetes in US youth in 2009: the SEARCH for diabetes in youth study. Diabetes Care. 2014;37:402–8.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Jin YY, Liang L, Fu JF, Wang XM. The tendency of constitutes of diabetes and incidence of type 2 diabetes mellitus in the children of Zhejiang province in the last ten years. J Chin Curr Pediatr. 2011;13:138–40. Jin YY, Liang L, Fu JF, Wang XM. The tendency of constitutes of diabetes and incidence of type 2 diabetes mellitus in the children of Zhejiang province in the last ten years. J Chin Curr Pediatr. 2011;13:138–40.
5.
Zurück zum Zitat Fu JF, Liang L, Gong CX, Xiong F, Luo FH, Liu GL, et al. Status and trends of diabetes in Chinese children: analysis of data from 14 medical centers. World J Pediatr. 2013;9:127–34.CrossRefPubMed Fu JF, Liang L, Gong CX, Xiong F, Luo FH, Liu GL, et al. Status and trends of diabetes in Chinese children: analysis of data from 14 medical centers. World J Pediatr. 2013;9:127–34.CrossRefPubMed
6.
Zurück zum Zitat Rosenbloom AL, Silverstein JH, Amemiya S, Zeitler P, Klingensmith GJ. International Society for Pediatric and Adolescent Diabetes. ISPAD Clinical Practice Consensus Guidelines 2006–2007. Type 2 diabetes mellitus in the child and adolescent. Pediatr Diabetes. 2008;9:512–26.CrossRefPubMed Rosenbloom AL, Silverstein JH, Amemiya S, Zeitler P, Klingensmith GJ. International Society for Pediatric and Adolescent Diabetes. ISPAD Clinical Practice Consensus Guidelines 2006–2007. Type 2 diabetes mellitus in the child and adolescent. Pediatr Diabetes. 2008;9:512–26.CrossRefPubMed
7.
Zurück zum Zitat Pulgaron ER, Delamater AM. Obesity and type 2 diabetes in children: epidemiology and treatment. Curr Diabetes Rep. 2014;14:508.CrossRef Pulgaron ER, Delamater AM. Obesity and type 2 diabetes in children: epidemiology and treatment. Curr Diabetes Rep. 2014;14:508.CrossRef
8.
Zurück zum Zitat NCD Risk Factor. Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet. 2017;390:2627–42.CrossRef NCD Risk Factor. Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet. 2017;390:2627–42.CrossRef
9.
Zurück zum Zitat Constantino MI, Molyneaux L, Limacher-Gisler F, Al-Saeed A, Luo C, Wu T, et al. Long-term complications and mortality in young-onset diabetes: type 2 diabetes is more hazardous and lethal than type 1 diabetes. Diabetes Care. 2013;36:3863–9.CrossRefPubMedPubMedCentral Constantino MI, Molyneaux L, Limacher-Gisler F, Al-Saeed A, Luo C, Wu T, et al. Long-term complications and mortality in young-onset diabetes: type 2 diabetes is more hazardous and lethal than type 1 diabetes. Diabetes Care. 2013;36:3863–9.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Dart AB, Martens PJ, Rigatto C, Brownell MD, Dean HJ, Sellers EA. Earlier onset of complications in youth with type 2 diabetes. Diabetes Care. 2014;37:436–43.CrossRefPubMed Dart AB, Martens PJ, Rigatto C, Brownell MD, Dean HJ, Sellers EA. Earlier onset of complications in youth with type 2 diabetes. Diabetes Care. 2014;37:436–43.CrossRefPubMed
11.
Zurück zum Zitat Li X, Deng YP, Yang M, Wu YW, Sun SX, Sun JZ. Triglyceride to high-density lipoprotein cholesterol ratio and carotid intima-medial thickness in Chinese adolescents with newly diagnosed type 2 diabetes mellitus. Pediatr Diabetes. 2016;17:87–92.CrossRefPubMed Li X, Deng YP, Yang M, Wu YW, Sun SX, Sun JZ. Triglyceride to high-density lipoprotein cholesterol ratio and carotid intima-medial thickness in Chinese adolescents with newly diagnosed type 2 diabetes mellitus. Pediatr Diabetes. 2016;17:87–92.CrossRefPubMed
12.
Zurück zum Zitat Gungor N, Arslanian S. Progressive beta cell failure in type 2 diabetes mellitus of youth. J Pediatr. 2004;144:656–9.CrossRefPubMed Gungor N, Arslanian S. Progressive beta cell failure in type 2 diabetes mellitus of youth. J Pediatr. 2004;144:656–9.CrossRefPubMed
13.
Zurück zum Zitat Bacha F, Gungor N, Lee S, Arslanian SA. Progressive deterioration of β-cell function in obese youth with type 2 diabetes. Pediatr Diabetes. 2013;14:106–11.CrossRefPubMed Bacha F, Gungor N, Lee S, Arslanian SA. Progressive deterioration of β-cell function in obese youth with type 2 diabetes. Pediatr Diabetes. 2013;14:106–11.CrossRefPubMed
14.
15.
Zurück zum Zitat Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes. 2003;52:102–10.CrossRefPubMed Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes. 2003;52:102–10.CrossRefPubMed
17.
Zurück zum Zitat Klingensmith GJ, Connor CG, Ruedy KJ, Beck RW, Kollman C, Haro H, et al. Presentation of youth with type 2 diabetes in the Pediatric Diabetes Consortium. Pediatr Diabetes. 2016;17:266–73.CrossRefPubMed Klingensmith GJ, Connor CG, Ruedy KJ, Beck RW, Kollman C, Haro H, et al. Presentation of youth with type 2 diabetes in the Pediatric Diabetes Consortium. Pediatr Diabetes. 2016;17:266–73.CrossRefPubMed
18.
Zurück zum Zitat Association American Diabetes. 2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S13–27.CrossRef Association American Diabetes. 2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S13–27.CrossRef
19.
Zurück zum Zitat Zeitler P, Arslanian S, Fu J, Pinhas-Hamiel O, Reinehr T, Tandon N, et al. ISPAD Clinical Practice Consensus Guidelines 2018: Type 2 diabetes mellitus in youth. Pediatr Diabetes. 2018;19(Suppl 27):28–46.CrossRefPubMed Zeitler P, Arslanian S, Fu J, Pinhas-Hamiel O, Reinehr T, Tandon N, et al. ISPAD Clinical Practice Consensus Guidelines 2018: Type 2 diabetes mellitus in youth. Pediatr Diabetes. 2018;19(Suppl 27):28–46.CrossRefPubMed
20.
Zurück zum Zitat Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9.CrossRefPubMed Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9.CrossRefPubMed
21.
Zurück zum Zitat National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114(2 Suppl 4th Report):555–76.CrossRef National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114(2 Suppl 4th Report):555–76.CrossRef
22.
Zurück zum Zitat Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Am J Gastroenterol. 2012;107:811–26.CrossRefPubMed Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Am J Gastroenterol. 2012;107:811–26.CrossRefPubMed
23.
Zurück zum Zitat Todd JN, Srinivasan S, Pollin TI. Advances in the genetics of youth-onset type 2 diabetes. Curr Diabetes Rep. 2018;18:57.CrossRef Todd JN, Srinivasan S, Pollin TI. Advances in the genetics of youth-onset type 2 diabetes. Curr Diabetes Rep. 2018;18:57.CrossRef
24.
Zurück zum Zitat American Diabetes Association. 12. Children and Adolescents: Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S126–36.CrossRef American Diabetes Association. 12. Children and Adolescents: Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S126–36.CrossRef
25.
Zurück zum Zitat Wu H, Zhong J, Yu M, Wang H, Gong W, Pan J, et al. Incidence and time trends of type 2 diabetes mellitus in youth aged 5–19 years: a population-based registry in Zhejiang, China, 2007 to 2013. BMC Pediatr. 2017;17:85.CrossRefPubMedPubMedCentral Wu H, Zhong J, Yu M, Wang H, Gong W, Pan J, et al. Incidence and time trends of type 2 diabetes mellitus in youth aged 5–19 years: a population-based registry in Zhejiang, China, 2007 to 2013. BMC Pediatr. 2017;17:85.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Zhu JF, Liang L, Fu JF, Gong CX, Xiong F, Liu GL, et al. The current study of lipid status in Chinese 7–16 years old schoolchildren from six main cities. Chin J Epidemiol. 2012;33:1016–20. Zhu JF, Liang L, Fu JF, Gong CX, Xiong F, Liu GL, et al. The current study of lipid status in Chinese 7–16 years old schoolchildren from six main cities. Chin J Epidemiol. 2012;33:1016–20.
27.
Zurück zum Zitat Zhang M, Guo F, Tu Y, Kiess W, Sun C, Li X, et al. Further increase of obesity prevalence in Chinese children and adolescents—cross-sectional data of two consecutive samples from the city of Shanghai from 2003 to 2008. Pediatr Diabetes. 2012;13:572–7.CrossRefPubMed Zhang M, Guo F, Tu Y, Kiess W, Sun C, Li X, et al. Further increase of obesity prevalence in Chinese children and adolescents—cross-sectional data of two consecutive samples from the city of Shanghai from 2003 to 2008. Pediatr Diabetes. 2012;13:572–7.CrossRefPubMed
28.
Zurück zum Zitat Copeland KC, Zeitler P, Geffner M, Guandalini C, Higgins J, Hirst K, et al. Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline. J Clin Endocrinol Metab. 2011;96:159–67.CrossRefPubMed Copeland KC, Zeitler P, Geffner M, Guandalini C, Higgins J, Hirst K, et al. Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline. J Clin Endocrinol Metab. 2011;96:159–67.CrossRefPubMed
29.
Zurück zum Zitat Scanu AM, Lawn RM, Berg K. Lipoprotein(a) and atherosclerosis. Ann Intern Med. 1991;115:209–18.CrossRefPubMed Scanu AM, Lawn RM, Berg K. Lipoprotein(a) and atherosclerosis. Ann Intern Med. 1991;115:209–18.CrossRefPubMed
30.
Zurück zum Zitat Petitti DB, Imperatore G, Palla SL, Daniels SR, Dolan LM, Kershnar AK, et al. Serum lipids and glucose control: the SEARCH for Diabetes in Youth study. Arch Pediatr Adolesc Med. 2007;161:159–65.CrossRefPubMed Petitti DB, Imperatore G, Palla SL, Daniels SR, Dolan LM, Kershnar AK, et al. Serum lipids and glucose control: the SEARCH for Diabetes in Youth study. Arch Pediatr Adolesc Med. 2007;161:159–65.CrossRefPubMed
31.
Zurück zum Zitat Bussler S, Penke M, Flemming G, Elhassan YS, Kratzsch J, Sergeyev E, et al. Novel insights in the metabolic syndrome in childhood and adolescence. Horm Res Paediatr. 2017;88:181–93.CrossRefPubMed Bussler S, Penke M, Flemming G, Elhassan YS, Kratzsch J, Sergeyev E, et al. Novel insights in the metabolic syndrome in childhood and adolescence. Horm Res Paediatr. 2017;88:181–93.CrossRefPubMed
32.
Zurück zum Zitat Ioannidis I. The road from obesity to type 2 diabetes. Angiology. 2008;59(2 Suppl):39S–43S.CrossRefPubMed Ioannidis I. The road from obesity to type 2 diabetes. Angiology. 2008;59(2 Suppl):39S–43S.CrossRefPubMed
33.
Zurück zum Zitat Kahn SE. Clinical review 135: the importance of beta-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab. 2001;86:4047–58.PubMed Kahn SE. Clinical review 135: the importance of beta-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab. 2001;86:4047–58.PubMed
34.
Zurück zum Zitat Elder DA, Hornung LN, Khoury JC, D’Alessio DA. β-cell function over time in adolescents with new type 2 diabetes and obese adolescents without diabetes. J Adolesc Health. 2017;61:703–8.CrossRefPubMedPubMedCentral Elder DA, Hornung LN, Khoury JC, D’Alessio DA. β-cell function over time in adolescents with new type 2 diabetes and obese adolescents without diabetes. J Adolesc Health. 2017;61:703–8.CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Zelada H, Carnero AM, Miranda-Hurtado C, Condezo-Aliaga D, Loza-Munarriz C, Aro-Guardia P, et al. Beta-cell function and insulin resistance among Peruvian adolescents with type 2 diabetes. J Clin Transl Endocrinol. 2016;5:15–20.PubMedPubMedCentral Zelada H, Carnero AM, Miranda-Hurtado C, Condezo-Aliaga D, Loza-Munarriz C, Aro-Guardia P, et al. Beta-cell function and insulin resistance among Peruvian adolescents with type 2 diabetes. J Clin Transl Endocrinol. 2016;5:15–20.PubMedPubMedCentral
Metadaten
Titel
Clinical characteristics and beta-cell function of Chinese children and adolescents with type 2 diabetes from 2009 to 2018
verfasst von
Zhen-Ran Xu
Miao-Ying Zhang
Jin-Wen Ni
Ruo-Qian Cheng
Zhang-Qian Zheng
Li Xi
Fei-Hong Luo
Publikationsdatum
25.03.2019
Verlag
Springer Singapore
Erschienen in
World Journal of Pediatrics / Ausgabe 4/2019
Print ISSN: 1708-8569
Elektronische ISSN: 1867-0687
DOI
https://doi.org/10.1007/s12519-019-00243-5

Weitere Artikel der Ausgabe 4/2019

World Journal of Pediatrics 4/2019 Zur Ausgabe

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Begünstigt Bettruhe der Mutter doch das fetale Wachstum?

Ob ungeborene Kinder, die kleiner als die meisten Gleichaltrigen sind, schneller wachsen, wenn die Mutter sich mehr ausruht, wird diskutiert. Die Ergebnisse einer US-Studie sprechen dafür.

Bei Amblyopie früher abkleben als bisher empfohlen?

22.05.2024 Fehlsichtigkeit Nachrichten

Bei Amblyopie ist das frühzeitige Abkleben des kontralateralen Auges in den meisten Fällen wohl effektiver als der Therapiestandard mit zunächst mehrmonatigem Brilletragen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.